Buy the full study
Summary of our market study
The French market for nutraceuticals is estimated at between €20 and €30 billion.
A contraction of the terms "food" and "medicine", "alicament" is a marketing concept that globally designates food products that claim health benefits. Nutraceuticals and dietary foods are also often referred to as alicaments.
The global nutraceuticals market, valued at over $200 billion, is undergoing changes marked by consumer skepticism and regulatory measures to ensure the veracity of health claims. Growth prospects remain positive, with annual market growth of 3.14% between 2021 and 2025.
The Asia-Pacific region is expected to be the future growth driver, with the market set to rise from 391 billion euros in 2020 to 573 billion in 2030.
Consumer trends point to a demand for products designed to improve the health, cognitive functions and well-being of an ageing population. Probiotics are growing fast, and FoodTech innovations are driving the sector forward.
Regulatory oversight in Europe, with over 85% of negative EFSA opinions on health claims, is shaping the market, demanding clear, scientifically-based communications from companies.
The French nutraceuticals market: a blend of nutritional needs and medical benefits
The French market for nutraceuticals and dietary foods, often referred to as nutraceuticals, has experienced a complex dynamic of growth and stagnation.
The French health food market, which has long grown at a rate of 9-10% a year, is experiencing a slowdown, mainly due to increased scrutiny of exaggerated claims of health benefits. Nevertheless, the industry remains significant, and it is estimated that it will have reached a market size of between 10 and 20 billion euros by 2022.
This segment could see a revival due to an aging population, the rise of chronic health problems such as obesity, the quest for wellness and technological advances in FoodTech.
Projections indicate that by 2050, more than a quarter of the French population will be over 65, and one in ten people will be over 90.
Almost half the French population is overweight or obese.
92% of French citizens rank healthcare among their top priorities when it comes to political choices.
Certain market niches, such as probiotics, have seen impressive growth. The probiotics market has exceeded 100 million euros in France. In addition to probiotics, segments concerning stress relief, sleep enhancement and cognitive functions (nootropics) continue to attract consumer interest.
Nutraceutical market players
- Danone: Probiotic-rich products such as Actimel and Activia.
- Nestlé has entered the nutraceuticals market. The acquisition of Novartis' medical nutrition division catapulted Nestlé into a leading position.
- Lesieur: By enriching its Isio Mémo oil with DHA, an omega-3 fatty acid essential for brain health, Lesieur has succeeded in establishing itself as a forerunner in the cognitive well-being niche.
- Lactalis has broadened its horizons by taking an interest in sports nutrition, a segment that is recording remarkable growth.
- St Hubert: With products such as margarine enriched with omega-3, St Hubert has found its niche in the fight against cholesterol and cardiovascular disease.
- Innocent: Known for its juices and smoothies that combine health benefits with the convenience and appeal of a ready-to-drink format.
- Orangina Schweppes France stands out for its decision to buck the trend.
to understand this market
Detailed content of our market study
Inforamtion
- Number of pages : ~ 40 pages
- Format : Digital and PDF versions
- Last update :
Summary and extracts
1 Market overview
1.1 Introduction
An alicament (or "medicaliment", or "nutraceutical") is a food with pharmaceutical properties. It may be a natural food containing active molecules, or an artificially enriched industrial food. This designation can be detrimental to the nutraceutical trade, as it raises a number of ethical and commercial issues. the current market segmentation distinguishes between industrial foods (such as Omega-3 enriched foods, foods rich in active Bifidus, etc.) and natural foods (such as herbal or phytotherapeutic products).
The health food market seems to be marking time after a rather flourishing 1990-2000 period. This is due to marketing abuses extolling the virtues of products with health benefits far in excess of their actual effects on the body, prompting consumers to speak of a veritable "scam". In the United States, Danone was fined tens of millions of dollars following a complaint from consumers who doubted the benefits ofActimel. European regulations ensure that advertising deemed to be misleading is eradicated.
All the companies present in this market are heavyweights in the food industry. Competition is therefore extreme in a global health food market worth over $200 billion.
The problem for the sector is to justify the price difference to consumers (Bifidus yoghurt costs twice as much as conventional yoghurt). The European Food Safety Agency (EFSA), which is responsible for examining claims, has examined 1,750 of the 4,200 submitted, with 85% of negative opinions to date.
List of charts presented in this market study
- Sales growth forecast for the food sector
- Sales forecast for the nutraceuticals market
- High estimate of growth in the health food market
- Nearly one French person in two is overweight or obese
- Share of population by age bracket
All our studies are available online in PDF format
Take a look at an example of our research on another market!
Latest news
At the bedside of the sick, Danone invests in protein drinks at Steenvoorde - 22/05/2024
- The adult medical nutrition market is estimated at several billion euros worldwide.
- - Danone is number one in Europe and number two worldwide in the medical nutrition sector.
- - Blédina's Steenvoorde plant will manufacture protein-enriched drinks under the Fortimel brand
- - The total investment for this project is 70 million euros
- - Danone currently operates seven plants worldwide in the medical nutrition sector, including five in Europe.
- - Sales of Danone's specialized nutrition division are expected to reach 8.5 billion in 2023
- - Danone has invested in Turkey and Poland to increase its production capacity in medical nutrition, and has acquired Functional Formularies in the United States.
Danone bets more than ever on medical nutrition - 21/05/2024
- Investment of 70 million euros in a new production line dedicated to medical nutrition at the Blédina plant in Steenvorde.
- Danone's specialized nutrition division, including medical nutrition, generated sales of 8.3 billion euros in 2023.
- Growth of 6.7% for this division in 2023.
- Acquisition of Promedica in Poland, specialized in home enteral tube feeding.
- Acquisition of US-based Functional Formularies, with sales of around 27 million euros, specializing in biological tube-feeding formulas.
- Investment of 100 million euros in a new international R&D center in Saclay, to be inaugurated in February 2023.
Danone opens a second plant for plant-based products in France - 12/02/2024
- Danone inaugurates a new plant dedicated to the manufacture of dairy alternatives in France
- Danone has completely converted its Villecomtal-sur-Arros yogurt plant in the Gers department into a unit dedicated to Alpro-brand plant-based beverages. 43 million euros of investment
- Production, mainly of oat juice cartons, is 90% destined for Europe.
- Danone now has four milk-alternative production units in Europe. Two in France, at Issenheim and Villecomtal in the Gers region, one in Sweden, at Lunnarp, and the fourth at Wevelgem in Belgium.
- Vegetable-based products have become "a strategic focus" for the world's number one in ultra-fresh products.
- Danone took the t turn in 2017 with the $12.5 billion acquisition of US group WhiteWave.
- In France, ultra-fresh products are deeply rooted in diets.
- Plant milk accounts for just 4% of the traditional dairy products market by volume and 7.4% by value.
- The plant-based milk market is worth 165 million euros, according to FranceAgriMer.
- More than 6 out of ten people in France in the 18-24 age bracket eat plant-based products several times a week, according to lDanone
- Many dairy groups, including Triballat, Nestlé and Bel, have chosen to develop plant-based ranges.
- Retail chains are present under their own brands (MDD).
Nestlé sells its Natur baby food products to FNB - 06/02/2024
- nestlé is the world's number one food company.
- FNB is a French investment fund specializing in small and medium-sized food companies.
- Nestlé is in exclusive negotiations with FNB to sell its baby food business in France.
- The products concerned are NaturNes baby food jars, Babicao and Babivanille infant powders, and the P'tit yogurt range.
- These products are produced at the Arches plant.
- Worldwide sales of Nestlé infant formulas rose by more than 10%.
Nestlé France sells its baby food products to Mousline - 02/02/2024
- Nestlé is in exclusive negotiations with French investment fund FnB for the sale of its baby food business.
- The ranges concerned are soups, purées, desserts and breakfast powders under the NaturNes, Babicao, Babivanille brands and the P'tit franchise.
- Infant milks, the bulk of the portfolio - with Laboratoires Guigoz and Nestlé Nidal - remain within the Nestlé France fold.
- The infant nutrition products targeted by this sale are produced in a factory in the Vosges region of France, which employs 230 people.
- FnB, the potential buyer, specializes in supporting French SMEs in the food industry.
- The infant food market in France shrank by 6% in volume last year due to the drop in the birth rate, with a sharper decline in milks than in diversification foods.
- Nestlé has 14 factories in France.
Danone sells its US organic dairy business to Platinum Equity - 02/01/2024
- Danone has signed an agreement to sell its US organic dairy business to Platinum Equity.
- The sale concerns the Horizon Organic and Wallaby businesses.
- By 2022, Horizon Organic and Wallaby represented around 3% of Danone's total sales.
Companies quoted in this study
This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :
Choosing this study means :
Access to more than 35 hours of work
Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.
Benefit from 6 years' experience and over 1,500 industry reports already produced
Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.
Our know-how and methodology enable us to produce reports that offer unique value for money.
Access to several thousand articles and paid-for data
Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).
To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)
Guaranteed support after your purchase
A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676
A digital format designed for our users
Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.
Our offers :
the alicaments market | France
- What are the figures on the size and growth of the market?
- What is driving the growth of the market and its evolution?
- What is the positioning of companies in the value chain?
- Data from several dozen databases
Pack 5 études (-15%) France
- 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
- Conservez -15% sur les études supplémentaires achetées
- Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)
Consultez les conditions du pack et de remboursement des crédits non consommés.
Our customer references
They have consulted our studies
Discover the opinions (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & case studies
All interviews and case studies (45)
